Short description
Congruence Therapeutics operates as a biotechnology company.
Description
Congruence Therapeutics operates as a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.
Last funding
Cannot Access
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Montréal, Quebec, Canada, North America
Founded on
January 1, 2021
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Cannot Access, Cannot Access, Absolutely Noaccess, Nopepepe, Blurry Noaccess, Cannot Access, Cannot Access, Cannot Access, Blurry Noaccess, No Way
Sign in for full access